Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Jun 18, 2025
Open Peer Review Period: Jun 20, 2025 - Aug 15, 2025
Date Accepted: Nov 20, 2025
Date Submitted to PubMed: Nov 21, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Enhancing Safety in Clinical Practice: Cross-Sectional, Within-Subjects, Simulated-Use Compliance Study Using BD PosiFlush SafeScrub

De Boer K, Simpson J, Sharma P, Steele TJ

Enhancing Safety in Clinical Practice: Cross-Sectional, Within-Subjects, Simulated-Use Compliance Study Using BD PosiFlush SafeScrub

JMIR Hum Factors 2025;12:e78967

DOI: 10.2196/78967

PMID: 41269868

PMCID: 12750072

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Enhancing Safety in Clinical Practice: A Cross-sectional, within-subjects, simulated-use compliance study using BD PosiFlush™ SafeScrub

  • Kyle De Boer; 
  • John Simpson; 
  • Purnima Sharma; 
  • Trevor J Steele

ABSTRACT

Background:

Needleless access devices are integral to intravenous therapy, but they can also be a source of contamination and potential infection if not properly disinfected and cared for. The BD PosiFlush™ SafeScrub is designed to streamline best practice “scrub the hub” catheter care; and may reduce the microbial growth associated with catheter related blood stream infections (CRBSIs).

Objective:

The objective of this study was to evaluate the compliance of scrubbing prior to flushing with the BD PosiFlush™ SafeScrub in a simulated clinical environment, in comparison to a standard disinfection practice of alcohol swabs and pre-filled saline syringes.

Methods:

A cross-sectional, within-subjects, simulated-use compliance study was conducted involving healthcare professionals who were familiarized in the use of BD PosiFlush™ SafeScrub, which is a BD PosiFlush™ Syringe with an integrated disinfecting unit. The compliance with disinfection was monitored and recorded for both the BD PosiFlush™ SafeScrub and standard disinfection practice (alcohol swabs and pre-filled saline syringes).

Results:

The BD PosiFlush™ SafeScrub, with an integrated disinfection unit, demonstrated a total compliance rate of 34% for scrubbing catheter hubs prior to flushing. This represents a significant increase when compared with the 17% compliance rate (P < .001) achieved using the current widely accepted practice of alcohol swabs and pre-filled saline syringes. Use of BD PosiFlush™ SafeScrub demonstrated a statistically significant improvement in compliance with disinfection practice compared to the standard disinfection practice.

Conclusions:

The BD PosiFlush™ SafeScrub device approximately doubled the scrub the hub compliance before flushing over the standard practice of alcohol pads and pre-filled saline syringes.


 Citation

Please cite as:

De Boer K, Simpson J, Sharma P, Steele TJ

Enhancing Safety in Clinical Practice: Cross-Sectional, Within-Subjects, Simulated-Use Compliance Study Using BD PosiFlush SafeScrub

JMIR Hum Factors 2025;12:e78967

DOI: 10.2196/78967

PMID: 41269868

PMCID: 12750072

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.